Preferred Label : corifollitropin alfa;
UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T125 - Hormone;
Is substance : O;
Origin ID : M0536836;
UMLS CUI : C2713522;
ATC code(s)
CISMeF manual mappings
Related record
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3409400/fr/elonva-corifollitropine-alfa-hypogonadisme-hypogonadotrope-hh
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
corifollitropin alfa
corifollitropin alfa
hypogonadotropic hypogonadism
drug therapy, combination
adolescent
adult
evaluation of the transparency committee
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=66844562
2014
false
false
false
France
French
summary of product characteristics
package leaflet
corifollitropin alfa
solutions
injection, nos
injections
solution, nos
follicle stimulating hormone, human, with HCG C-terminal peptide
solutions
follicle stimulating hormone, human
---
http://www.meddispar.fr/Medicaments/ELONVA-150-B-1/(type)/letter/(value)/E/(cip)/3400937459181
2014
false
true
false
France
French
drug information
legislation, drug
drug prescriptions
corifollitropin alfa
continuity of patient care
corifollitropin alfa
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64036190
2014
false
false
false
France
French
package leaflet
summary of product characteristics
injection, nos
injections
solutions
corifollitropin alfa
solution, nos
solutions
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
---
http://www.meddispar.fr/Medicaments/ELONVA-100-B-1/(type)/letter/(value)/E/(cip)/3400937459013
2014
false
true
false
France
French
drug information
legislation, drug
drug prescriptions
corifollitropin alfa
corifollitropin alfa
continuity of patient care
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
---
https://www.ema.europa.eu/medicines/human/EPAR/Elonva
2012
false
United Kingdom
English
French
syndication feed
follicle stimulating hormone, human
corifollitropin alfa
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
infertility, female
injections, subcutaneous
drug approval
drug labeling
treatment outcome
pregnancy
breast feeding
drug therapy, combination
ovulation induction
anovulation
ovarian follicle
corifollitropin alfa
corifollitropin alfa
follicle stimulating hormone, human
drug evaluation
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_990918/elonva
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/elonva_-_ct-_8390.pdf
http://www.has-sante.fr/portail/jcms/c_1261511/elonva-ct-8390-version-anglaise
2010
false
France
French
English
follicle stimulating hormone, human, with HCG C-terminal peptide
injections, subcutaneous
insurance, health, reimbursement
treatment outcome
corifollitropin alfa
follicle stimulating hormone, human
recombinant proteins
drug therapy, combination
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
anovulation
Delayed-Action preparations
ovulation induction
ovarian follicle
corifollitropin alfa
corifollitropin alfa
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1014496/elonva-corifollitropine-alfa-stimulant-folliculaire-a-activite-prolongee
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/elonva_-_ct-_8390.pdf
2010
false
France
French
Delayed-Action preparations
anovulation
recombinant proteins
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
corifollitropin alfa
insurance, health, reimbursement
ovarian follicle
ovulation induction
drug therapy, combination
treatment outcome
injections, subcutaneous
follicle stimulating hormone, human, with HCG C-terminal peptide
follicle stimulating hormone, human
corifollitropin alfa
corifollitropin alfa
guidelines for drug use
evaluation of the transparency committee
---